New Information Campaigns…”Can’t Pass It On” and “U=U”

There are a couple of campaigns that are trying to reduce the stigma associated with HIV. Both have the same message, but use different slogans. THT has a campaign called “Can’t Pass it on”: http://www.tht.org.uk/sexual-health/About-HIV/Can_apos_t-Pass-It-On?utm_source=Terrence%20Higgins%20Trust%20newsletters&utm_medium=email&utm_campaign=8390497_Can%27t%20Pass%20It%20On%20launch%20-%20members%20and%20volunteers&dm_i=5HE,4ZU5D,GNFZ55,J0X60,1 They say: Medical evidence has shown that people on effective HIV treatment can’t pass it on. If everyone knew this, we […]

Bone Fractures Occur at an Earlier Age Among Men with HIV

Rates of osteopenia (low bone mineral density – BMD) and osteoporosis are higher in people living with HIV (PLWH) than in the general population. It’s possible that HIV itself or the body’s response to HIV may contribute to bone problems. In addition, many people living with HIV smoke, drink, don’t get enough exercise or have […]

Breathlessness, coughing and respiratory problems

Thanks to ART, many HIV-positive people now have a near-normal life expectancy. However, rates of heart, liver and kidney disease remain higher, compared with the general population. Research involving US military veterans also found that HIV-positive people had a significantly higher rate of chronic obstructive pulmonary disease (COPD). Investigators at the Royal Free Hospital, London, wanted to further […]

International Clinical Trials Day

International Clinical Trials Day is celebrated around the world on or near May 20th each year in order to commemorate the day that a Scottish naval surgeon, James Lind, conducted what is often considered the first randomized clinical trial aboard a ship on May 20th, 1747. In 1747, surgeon mate James Lind administered six different […]

Switching from Efavirenz Does Not Improve Cognitive Function

Despite effective antiretroviral therapy (ART), mild cognitive impairment (things like decreased attention span, poorer memory, worse problem-solving ability) remains common in people living with HIV. The reasons for this are poorly understood and little is known about the impact of specific anti-HIV drugs on neurological function. However, efavirenz – one of the most commonly used antiretrovirals […]

Life Expectancy Near Normal

A large study of 88,504 people with HIV on antiretroviral therapy (ART), published in the Lancet journal and reported widely in the news, has found substantial improvements in life expectancy in people with HIV who started ART after 2008, even in their first year of therapy. People who started ART in 2008-2010 and who had […]

HCV Transmission in MSM

HCV is primarily a blood borne infection, so sex that includes blood-to-blood has the highest risk. In MSM, this has led to the view that the risk of transmission is high when using sex toys, fisting, “slamming”, chemsex, and “rough sex”. Although HCV has been found in semen, and also in vaginal fluid, until now […]

Generic HIV Drugs

The financial pressures faced by HIV clinics in the NHS was a major theme of the recent British HIV Association conference. Doctors discussed how they can keep costs down without compromising the quality of care. One of the most important ways they can do so is to switch some patients from branded, expensive drugs to […]

Co-infection with HCV increases cancer risk for people with HIV

As a result of highly-active antiretroviral therapy (HAART), many people with HIV now have a near-normal life expectancy. However, rates of serious non-HIV-related illnesses are higher among people with HIV compared to individuals in the general population. Several studies have shown that even for people taking effective HAART, they have higher risk of several malignancies not traditionally associated […]